Abstract
Inherited neuromuscular disorders (NMDs) form a group of highly heterogeneous diseases with a relatively high incidence of 1 in 3000. NMDs affect the peripheral nervous and muscular systems, resulting in gross motor disability. Disease subtype diagnosis is complicated by the high clinical and genetic heterogeneities of the disease and consequently more than 50% of the cases remain molecularly uncharacterized. Traditional gene-by-gene approach is quite exhaustive and after a few negative tests the quest for diagnosis is often given up without establishing diagnosis. However in the recent years, the clinical applications of next-generation sequencing (NGS)-based comprehensive approach such as multi-gene panels, and exome sequencing have allowed for rapid diagnosis. Additionally, its applications in research settings have allowed for identification of new disease-causing genes and variants which translated into an improved clinical diagnostic yield. Here, we discuss the application of NGS technology in NMDs as a diagnostic and research tool. We conclude that such an application will tremendously broaden our knowledge of NMDs; the outcome of which includes rapid and accurate diagnosis that would result in an earlier and more effective intervention.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Emery, A.E.: Population frequencies of inherited neuromuscular diseases – a world survey. Neuromuscul. Disord. NMD. 1, 19–29 (1991)
North, K.: What’s new in congenital myopathies? Neuromuscul. Disord. NMD. 18, 433–442 (2008). doi:10.1016/j.nmd.2008.04.002
Valencia, C.A., Ankala, A., Rhodenizer, D., et al.: Comprehensive mutation analysis for congenital muscular dystrophy: a clinical PCR-based enrichment and next-generation sequencing panel. PLoS One. 8, e53083 (2013). doi:10.1371/journal.pone.0053083
Vasli, N., Böhm, J., Le Gras, S., et al.: Next generation sequencing for molecular diagnosis of neuromuscular diseases. Acta Neuropathol. (Berl). 124, 273–283 (2012). doi:10.1007/s00401-012-0982-8
Flanigan, K.M.: The muscular dystrophies. Semin. Neurol. 32, 255–263 (2012). doi:10.1055/s-0032-1329199
Mercuri, E., Muntoni, F.: Muscular dystrophies. Lancet. 381, 845–860 (2013). doi:10.1016/S0140-6736(12)61897-2
Rocha, C.T., Hoffman, E.P.: Limb-girdle and congenital muscular dystrophies: current diagnostics, management, and emerging technologies. Curr. Neurol. Neurosci. Rep. 10, 267–276 (2010). doi:10.1007/s11910-010-0119-1
Mercuri, E., Muntoni, F.: The ever-expanding spectrum of congenital muscular dystrophies. Ann. Neurol. 72, 9–17 (2012). doi:10.1002/ana.23548
Saporta, A.S.D., Sottile, S.L., Miller, L.J., et al.: Charcot-Marie-Tooth disease subtypes and genetic testing strategies. Ann. Neurol. 69, 22–33 (2011). doi:10.1002/ana.22166
North, K.N., Wang, C.H., Clarke, N., et al.: Approach to the diagnosis of congenital myopathies. Neuromuscul. Disord. NMD. 24, 97–116 (2014). doi:10.1016/j.nmd.2013.11.003
Nance, J.R., Dowling, J.J., Gibbs, E.M., Bönnemann, C.G.: Congenital myopathies: an update. Curr. Neurol. Neurosci. Rep. 12, 165–174 (2012). doi:10.1007/s11910-012-0255-x
Richard, P., Charron, P., Carrier, L., et al.: Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation. 107, 2227–2232 (2003). doi:10.1161/01.CIR.0000066323.15244.54
Villard, E., Duboscq-Bidot, L., Charron, P., et al.: Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene. Eur. Heart J. 26, 794–803 (2005). doi:10.1093/eurheartj/ehi193
Meredith, C., Herrmann, R., Parry, C., et al.: Mutations in the slow skeletal muscle fiber myosin heavy chain gene (MYH7) cause laing early-onset distal myopathy (MPD1). Am. J. Hum. Genet. 75, 703–708 (2004). doi:10.1086/424760
Tajsharghi, H., Thornell, L.-E., Lindberg, C., et al.: Myosin storage myopathy associated with a heterozygous missense mutation in MYH7. Ann. Neurol. 54, 494–500 (2003). doi:10.1002/ana.10693
Tajsharghi, H., Oldfors, A., Macleod, D.P., Swash, M.: Homozygous mutation in MYH7 in myosin storage myopathy and cardiomyopathy. Neurology. 68, 962 (2007). doi:10.1212/01.wnl.0000257131.13438.2c
Muelas, N., Hackman, P., Luque, H., et al.: MYH7 gene tail mutation causing myopathic profiles beyond Laing distal myopathy. Neurology. 75, 732–741 (2010). doi:10.1212/WNL.0b013e3181eee4d5
Pegoraro, E., Gavassini, B.F., Borsato, C., et al.: MYH7 gene mutation in myosin storage myopathy and scapulo-peroneal myopathy. Neuromuscul. Disord. NMD. 17, 321–329 (2007). doi:10.1016/j.nmd.2007.01.010
Ortolano, S., Tarrío, R., Blanco-Arias, P., et al.: A novel MYH7 mutation links congenital fiber type disproportion and myosin storage myopathy. Neuromuscul. Disord. NMD. 21, 254–262 (2011). doi:10.1016/j.nmd.2010.12.011
Homayoun, H., Khavandgar, S., Hoover, J.M., et al.: Novel mutation in MYH7 gene associated with distal myopathy and cardiomyopathy. Neuromuscul. Disord. NMD. 21, 219–222 (2011). doi:10.1016/j.nmd.2010.12.005
Gazzerro, E., Bonetto, A., Minetti, C.: Caveolinopathies: translational implications of caveolin-3 in skeletal and cardiac muscle disorders. Handb. Clin. Neurol. 101, 135–142 (2011). doi:10.1016/B978-0-08-045031-5.00010-4
Fee, D.B., So, Y.T., Barraza, C., et al.: Phenotypic variability associated with Arg26Gln mutation in caveolin3. Muscle Nerve. 30, 375–378 (2004). doi:10.1002/mus.20092
Rosen, D.R., Siddique, T., Patterson, D., et al.: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 362, 59–62 (1993). doi:10.1038/362059a0
Chen, Y.-Z., Bennett, C.L., Huynh, H.M., et al.: DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am. J. Hum. Genet. 74, 1128–1135 (2004). doi:10.1086/421054
Hadano, S., Hand, C.K., Osuga, H., et al.: A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat. Genet. 29, 166–173 (2001). doi:10.1038/ng1001-166
Yang, Y., Hentati, A., Deng, H.X., et al.: The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat. Genet. 29, 160–165 (2001). doi:10.1038/ng1001-160
Gitcho, M.A., Bigio, E.H., Mishra, M., et al.: TARDBP 3′-UTR variant in autopsy-confirmed frontotemporal lobar degeneration with TDP-43 proteinopathy. Acta Neuropathol. (Berl). 118, 633–645 (2009). doi:10.1007/s00401-009-0571-7
Kwiatkowski, T.J., Bosco, D.A., Leclerc, A.L., et al.: Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 323, 1205–1208 (2009). doi:10.1126/science.1166066
Greenway, M.J., Alexander, M.D., Ennis, S., et al.: A novel candidate region for ALS on chromosome 14q11.2. Neurology. 63, 1936–1938 (2004)
Hayward, C., Colville, S., Swingler, R.J., Brock, D.J.: Molecular genetic analysis of the APEX nuclease gene in amyotrophic lateral sclerosis. Neurology. 52, 1899–1901 (1999)
DeJesus-Hernandez, M., Mackenzie, I.R., Boeve, B.F., et al.: Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF7 auses chromosome 9p-linked FTD and ALS. Neuron. 72, 245–256 (2011). doi:10.1016/j.neuron.2011.09.011
Renton, A.E., Majounie, E., Waite, A., et al.: A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 72, 257–268 (2011). doi:10.1016/j.neuron.2011.09.010
Lo, H.P., Cooper, S.T., Evesson, F.J., et al.: Limb-girdle muscular dystrophy: diagnostic evaluation, frequency and clues to pathogenesis. Neuromuscul. Disord. NMD. 18, 34–44 (2008). doi:10.1016/j.nmd.2007.08.009
Peat, R.A., Smith, J.M., Compton, A.G., et al.: Diagnosis and etiology of congenital muscular dystrophy. Neurology. 71, 312–321 (2008). doi:10.1212/01.wnl.0000284605.27654.5a
Chae, J.H., Vasta, V., Cho, A., et al.: Utility of next generation sequencing in genetic diagnosis of early onset neuromuscular disorders. J. Med. Genet. 52, 208–216 (2015). doi:10.1136/jmedgenet-2014-102819
Jungbluth, H., Sewry, C.A., Counsell, S., et al.: Magnetic resonance imaging of muscle in nemaline myopathy. Neuromuscul. Disord. NMD. 14, 779–784 (2004). doi:10.1016/j.nmd.2004.08.005
Mercuri, E., Jungbluth, H., Muntoni, F.: Muscle imaging in clinical practice: diagnostic value of muscle magnetic resonance imaging in inherited neuromuscular disorders. Curr. Opin. Neurol. 18, 526–537 (2005)
Fischer, D., Kley, R.A., Strach, K., et al.: Distinct muscle imaging patterns in myofibrillar myopathies. Neurology. 71, 758–765 (2008). doi:10.1212/01.wnl.0000324927.28817.9b
Klein, A., Jungbluth, H., Clement, E., et al.: Muscle magnetic resonance imaging in congenital myopathies due to ryanodine receptor type 1 gene mutations. Arch. Neurol. 68, 1171–1179 (2011). doi:10.1001/archneurol.2011.188
Ghaoui, R., Clarke, N., Hollingworth, P., Needham, M.: Muscle disorders: the latest investigations. Intern. Med. J. 43, 970–978 (2013). doi:10.1111/imj.12234
Bornemann, A., Petersen, M.B., Schmalbruch, H.: Fatal congenital myopathy with actin filament deposits. Acta Neuropathol. (Berl). 92, 104–108 (1996)
Laing, N.G., Wallgren-Pettersson, C.: 161st ENMC international workshop on nemaline myopathy and related disorders, Newcastle upon Tyne, 2008. Neuromuscul. Disord. NMD. 19, 300–305 (2009). doi:10.1016/j.nmd.2009.02.002
Nowak, K.J., Wattanasirichaigoon, D., Goebel, H.H., et al.: Mutations in the skeletal muscle alpha-actin gene in patients with actin myopathy and nemaline myopathy. Nat. Genet. 23, 208–212 (1999). doi:10.1038/13837
Goebel, H.H., Piirsoo, A., Warlo, I., et al.: Infantile intranuclear rod myopathy. J. Child Neurol. 12, 22–30 (1997)
Sewry, C.A., Holton, J.L., Dick, D.J., et al.: Zebra body myopathy is caused by a mutation in the skeletal muscle actin gene (ACTA1). Neuromuscul. Disord. NMD. (2015). doi:10.1016/j.nmd.2015.02.003
Laing, N.G., Clarke, N.F., Dye, D.E., et al.: Actin mutations are one cause of congenital fibre type disproportion. Ann. Neurol. 56, 689–694 (2004). doi:10.1002/ana.20260
Hung, R.M., Yoon, G., Hawkins, C.E., et al.: Cap myopathy caused by a mutation of the skeletal alpha-actin gene ACTA1. Neuromuscul. Disord. NMD. 20, 238–240 (2010). doi:10.1016/j.nmd.2010.01.011
Zvaritch, E., Kraeva, N., Bombardier, E., et al.: Ca2+ dysregulation in Ryr1(I4895T/wt) mice causes congenital myopathy with progressive formation of minicores, cores, and nemaline rods. Proc. Natl. Acad. Sci. U. S. A. 106, 21813–21818 (2009). doi:10.1073/pnas.0912126106
Tennyson, C.N., Klamut, H.J., Worton, R.G.: The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced. Nat. Genet. 9, 184–190 (1995). doi:10.1038/ng0295-184
Hackman, P., Vihola, A., Haravuori, H., et al.: Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin. Am. J. Hum. Genet. 71, 492–500 (2002). doi:10.1086/342380
Donner, K., Sandbacka, M., Lehtokari, V.-L., et al.: Complete genomic structure of the human nebulin gene and identification of alternatively spliced transcripts. Eur. J. Hum. Genet. EJHG. 12, 744–751 (2004). doi:10.1038/sj.ejhg.5201242
Phillips, M.S., Fujii, J., Khanna, V.K., et al.: The structural organization of the human skeletal muscle ryanodine receptor (RYR1) gene. Genomics. 34, 24–41 (1996). doi:10.1006/geno.1996.0238
Abbs, S., Bobrow, M.: Analysis of quantitative PCR for the diagnosis of deletion and duplication carriers in the dystrophin gene. J. Med. Genet. 29, 191–196 (1992)
Muntoni, F., Torelli, S., Ferlini, A.: Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol. 2, 731–740 (2003)
Schouten, J.P., McElgunn, C.J., Waaijer, R., et al.: Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 30, e57 (2002)
van der Steege, G., Grootscholten, P.M., van der Vlies, P., et al.: PCR-based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy. Lancet. 345, 985–986 (1995)
Lemmers, R.J.F.L., Wohlgemuth, M., Frants, R.R., et al.: Contractions of D4Z4 on 4qB subtelomeres do not cause facioscapulohumeral muscular dystrophy. Am. J. Hum. Genet. 75, 1124–1130 (2004). doi:10.1086/426035
Warner, J.P., Barron, L.H., Goudie, D., et al.: A general method for the detection of large CAG repeat expansions by fluorescent PCR. J. Med. Genet. 33, 1022–1026 (1996)
Radvansky, J., Ficek, A., Kadasi, L.: Repeat-primed polymerase chain reaction in myotonic dystrophy type 2 testing. Genet. Test. Mol. Biomarkers. 15, 133–136 (2011). doi:10.1089/gtmb.2010.0127
Catalli, C., Morgante, A., Iraci, R., et al.: Validation of sensitivity and specificity of tetraplet-primed PCR (TP-PCR) in the molecular diagnosis of myotonic dystrophy type 2 (DM2). J. Mol. Diagn. JMD. 12, 601–606 (2010). doi:10.2353/jmoldx.2010.090239
Mardis, E.R.: The impact of next-generation sequencing technology on genetics. Trends Genet. TIG. 24, 133–141 (2008). doi:10.1016/j.tig.2007.12.007
Shendure, J., Ji, H.: Next-generation DNA sequencing. Nat. Biotechnol. 26, 1135–1145 (2008). doi:10.1038/nbt1486
Voelkerding, K.V., Dames, S.A., Durtschi, J.D.: Next-generation sequencing: from basic research to diagnostics. Clin. Chem. 55, 641–658 (2009). doi:10.1373/clinchem.2008.112789
Albert, T.J., Molla, M.N., Muzny, D.M., et al.: Direct selection of human genomic loci by microarray hybridization. Nat. Methods. 4, 903–905 (2007). doi:10.1038/nmeth1111
Hodges, E., Xuan, Z., Balija, V., et al.: Genome-wide in situ exon capture for selective resequencing. Nat. Genet. 39, 1522–1527 (2007). doi:10.1038/ng.2007.42
Okou, D.T., Steinberg, K.M., Middle, C., et al.: Microarray-based genomic selection for high-throughput resequencing. Nat. Methods. 4, 907–909 (2007). doi:10.1038/nmeth1109
Porreca, G.J., Zhang, K., Li, J.B., et al.: Multiplex amplification of large sets of human exons. Nat. Methods. 4, 931–936 (2007). doi:10.1038/nmeth1110
Ding, L., Getz, G., Wheeler, D.A., et al.: Somatic mutations affect key pathways in lung adenocarcinoma. Nature. 455, 1069–1075 (2008). doi:10.1038/nature07423
Kim, P.M., Lam, H.Y.K., Urban, A.E., et al.: Analysis of copy number variants and segmental duplications in the human genome: evidence for a change in the process of formation in recent evolutionary history. Genome Res. 18, 1865–1874 (2008). doi:10.1101/gr.081422.108
Tewhey, R., Warner, J.B., Nakano, M., et al.: Microdroplet-based PCR enrichment for large-scale targeted sequencing. Nat. Biotechnol. 27, 1025–1031 (2009). doi:10.1038/nbt.1583
Eid, J., Fehr, A., Gray, J., et al.: Real-time DNA sequencing from single polymerase molecules. Science. 323, 133–138 (2009). doi:10.1126/science.1162986
Borgström, E., Lundin, S., Lundeberg, J.: Large scale library generation for high throughput sequencing. PLoS One. 6, e19119 (2011). doi:10.1371/journal.pone.0019119
Margulies, M., Egholm, M., Altman, W.E., et al.: Genome sequencing in microfabricated high-density picolitre reactors. Nature. 437, 376–380 (2005). doi:10.1038/nature03959
Ruparel, H., Bi, L., Li, Z., et al.: Design and synthesis of a 3′-O-allyl photocleavable fluorescent nucleotide as a reversible terminator for DNA sequencing by synthesis. Proc. Natl. Acad. Sci. U. S. A. 102, 5932–5937 (2005). doi:10.1073/pnas.0501962102
Rothberg, J.M., Hinz, W., Rearick, T.M., et al.: An integrated semiconductor device enabling non-optical genome sequencing. Nature. 475, 348–352 (2011). doi:10.1038/nature10242
Clark, M.J., Chen, R., Lam, H.Y.K., et al.: Performance comparison of exome DNA sequencing technologies. Nat. Biotechnol. 29, 908–914 (2011). doi:10.1038/nbt.1975
Lin, X., Tang, W., Ahmad, S., et al.: Applications of targeted gene capture and next-generation sequencing technologies in studies of human deafness and other genetic disabilities. Hear. Res. 288, 67–76 (2012). doi:10.1016/j.heares.2012.01.004
Xie, S., Lan, Z., Qu, N., et al.: Detection of truncated dystrophin lacking the C-terminal domain in a Chinese pedigree by next-generation sequencing. Gene. 499, 139–142 (2012). doi:10.1016/j.gene.2012.03.029
Lim, B.C., Lee, S., Shin, J.-Y., et al.: Genetic diagnosis of Duchenne and Becker muscular dystrophy using next-generation sequencing technology: comprehensive mutational search in a single platform. J. Med. Genet. 48, 731–736 (2011). doi:10.1136/jmedgenet-2011-100133
Tian, X., Liang, W.-C., Feng, Y., et al.: Expanding genotype/phenotype of neuromuscular diseases by comprehensive target capture/NGS. Neurol. Genet. 1, e14 (2015). doi:10.1212/NXG.0000000000000015
Bennett, R.R., den Dunnen, J., O’Brien, K.F., et al.: Detection of mutations in the dystrophin gene via automated DHPLC screening and direct sequencing. BMC Genet. 2, 17 (2001)
Flanigan, K.M., von Niederhausern, A., Dunn, D.M., et al.: Rapid direct sequence analysis of the dystrophin gene. Am. J. Hum. Genet. 72, 931–939 (2003)
Lalic, T., Vossen, R.H.A.M., Coffa, J., et al.: Deletion and duplication screening in the DMD gene using MLPA. Eur. J. Hum. Genet. EJHG. 13, 1231–1234 (2005). doi:10.1038/sj.ejhg.5201465
Mendell, J.R., Buzin, C.H., Feng, J., et al.: Diagnosis of Duchenne dystrophy by enhanced detection of small mutations. Neurology. 57, 645–650 (2001)
Prior, T.W., Bridgeman, S.J.: Experience and strategy for the molecular testing of Duchenne muscular dystrophy. J. Mol. Diagn. JMD. 7, 317–326 (2005). doi:10.1016/S1525-1578(10)60560-0
Iglesias, A., Anyane-Yeboa, K., Wynn, J., et al.: The usefulness of whole-exome sequencing in routine clinical practice. Genet. Med. Off. J. Am. Coll. Med. Genet. 16, 922–931 (2014). doi:10.1038/gim.2014.58
Yang, Y., Muzny, D.M., Reid, J.G., et al.: Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N. Engl. J. Med. 369, 1502–1511 (2013). doi:10.1056/NEJMoa1306555
Stevens, E., Carss, K.J., Cirak, S., et al.: Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan. Am. J. Hum. Genet. 92, 354–365 (2013). doi:10.1016/j.ajhg.2013.01.016
Ceyhan-Birsoy, O., Talim, B., Swanson, L.C., et al.: Whole exome sequencing reveals DYSF, FKTN, and ISPD mutations in congenital muscular dystrophy without brain or eye involvement. J. Neuromuscul. Dis. 2, 87–92 (2015). doi:10.3233/JND-140038
Park, H.J., Choi, Y.C., Kim, S.M., et al.: Molecular genetic diagnosis of a Bethlem myopathy family with an autosomal-dominant COL6A1 mutation, as evidenced by exome sequencing. J. Clin. Neurol. Seoul Korea. 11, 183–187 (2015). doi:10.3988/jcn.2015.11.2.183
Bögershausen, N., Shahrzad, N., Chong, J.X., et al.: Recessive TRAPPC11 mutations cause a disease spectrum of limb girdle muscular dystrophy and myopathy with movement disorder and intellectual disability. Am. J. Hum. Genet. 93, 181–190 (2013). doi:10.1016/j.ajhg.2013.05.028
McDonald, K.K., Stajich, J., Blach, C., et al.: Exome analysis of two limb-girdle muscular dystrophy families: mutations identified and challenges encountered. PLoS One. 7, e48864 (2012). doi:10.1371/journal.pone.0048864
Harms, M.B., Sommerville, R.B., Allred, P., et al.: Exome sequencing reveals DNAJB6 mutations in dominantly-inherited myopathy. Ann. Neurol. 71, 407–416 (2012). doi:10.1002/ana.22683
Torella, A., Fanin, M., Mutarelli, M., et al.: Next-generation sequencing identifies transportin 3 as the causative gene for LGMD1F. PLoS One. 8, e63536 (2013). doi:10.1371/journal.pone.0063536
Carss, K.J., Stevens, E., Foley, A.R., et al.: Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan. Am. J. Hum. Genet. 93, 29–41 (2013). doi:10.1016/j.ajhg.2013.05.009
von Renesse, A., Petkova, M.V., Lützkendorf, S., et al.: POMK mutation in a family with congenital muscular dystrophy with merosin deficiency, hypomyelination, mild hearing deficit and intellectual disability. J. Med. Genet. 51, 275–282 (2014). doi:10.1136/jmedgenet-2013-102236
Couthouis, J., Raphael, A.R., Siskind, C., et al.: Exome sequencing identifies a DNAJB6 mutation in a family with dominantly-inherited limb-girdle muscular dystrophy. Neuromuscul. Disord. NMD. 24, 431–435 (2014). doi:10.1016/j.nmd.2014.01.014
Jimenez-Escrig, A., Gobernado, I., Garcia-Villanueva, M., Sanchez-Herranz, A.: Autosomal recessive Emery-Dreifuss muscular dystrophy caused by a novel mutation (R225Q) in the Lamin A/C gene identified by exome sequencing. Muscle Nerve. 45, 605–610 (2012). doi:10.1002/mus.22324
Mitsuhashi, S., Boyden, S.E., Estrella, E.A., et al.: Exome sequencing identifies a novel SMCHD1 mutation in facioscapulohumeral muscular dystrophy 2. Neuromuscul. Disord. NMD. 23, 975–980 (2013). doi:10.1016/j.nmd.2013.08.009
Manzini, M.C., Tambunan, D.E., Hill, R.S., et al.: Exome sequencing and functional validation in zebrafish identify GTDC2 mutations as a cause of Walker-Warburg syndrome. Am. J. Hum. Genet. 91, 541–547 (2012). doi:10.1016/j.ajhg.2012.07.009
Dias, C., Sincan, M., Cherukuri, P.F., et al.: An analysis of exome sequencing for diagnostic testing of the genes associated with muscle disease and spastic paraplegia. Hum. Mutat. 33, 614–626 (2012). doi:10.1002/humu.22032
Oliveira, J., Negrão, L., Fineza, I., et al.: New splicing mutation in the choline kinase beta (CHKB) gene causing a muscular dystrophy detected by whole-exome sequencing. J. Hum. Genet. (2015). doi:10.1038/jhg.2015.20
Shaheen, R., Faqeih, E., Ansari, S., Alkuraya, F.S.: A truncating mutation in B3GNT1 causes severe Walker-Warburg syndrome. Neurogenetics. 14, 243–245 (2013). doi:10.1007/s10048-013-0367-8
Klar, J., Sobol, M., Melberg, A., et al.: Welander distal myopathy caused by an ancient founder mutation in TIA1 associated with perturbed splicing. Hum. Mutat. 34, 572–577 (2013). doi:10.1002/humu.22282
Davies, K.E., Nowak, K.J.: Molecular mechanisms of muscular dystrophies: old and new players. Nat. Rev. Mol. Cell Biol. 7, 762–773 (2006). doi:10.1038/nrm2024
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Wang, L. et al. (2017). The Applications and Challenges of Next-Generation Sequencing in Diagnosing Neuromuscular Disorders. In: Wong, LJ. (eds) Next Generation Sequencing Based Clinical Molecular Diagnosis of Human Genetic Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-56418-0_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-56418-0_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-56416-6
Online ISBN: 978-3-319-56418-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)